ro13-9904 and Glioma
ro13-9904 has been researched along with Glioma* in 1 studies
Other Studies
1 other study(ies) available for ro13-9904 and Glioma
| Article | Year |
|---|---|
Unusual serological findings associated with ceftriaxone-induced immune hemolytic anemia in a child with disseminated low-grade glioma.
Ceftriaxone-induced immune hemolytic anemia (CIHA) is the second most common cause of drug-induced hemolytic anemia. Prompt recognition of this drug reaction is essential because brisk hemolysis can be deadly. The extent to which ceftriaxone antibodies persist after CIHA is unknown; rechallenging patients who have experienced CIHA is not recommended. We report a case of CIHA in a neurooncology patient, which is the first to show anticeftriaxone antibodies with Rh specificity and persisted for 8 months after the drug reaction. These findings have implications for understanding the mechanism of CIHA. Topics: Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antibodies; Brain Neoplasms; Ceftriaxone; Child, Preschool; Female; Glioma; Humans | 2016 |